| Name | 1-(4-chlorophenyl)-2-methylpropan-2-amine |
|---|---|
| Synonyms |
Lucofen SA
Chlorphenterminum [INN-Latin] Effox Chlorphenterminum Clorfentermina [INN-Spanish] 3-(4-chlorophenyl)-2-methyl-2-propylamin Clorfentermina Teramine chlorophentermine chlorphentermine Desopimon 1,1-dimethyl-2-(4-chlorophenyl)ethylamine |
| Density | 1.074g/cm3 |
|---|---|
| Boiling Point | 255.8ºC at 760mmHg |
| Molecular Formula | C10H14ClN |
| Molecular Weight | 183.67800 |
| Flash Point | 127ºC |
| Exact Mass | 183.08100 |
| PSA | 26.02000 |
| LogP | 3.32010 |
| Vapour Pressure | 0.016mmHg at 25°C |
| Index of Refraction | 1.537 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| HS Code | 29222900 |
|---|
|
~%
461-78-9 |
| Literature: Pathway Therapeutics Inc. Patent: US2012/252802 A1, 2012 ; Location in patent: Page/Page column 77 ; US 20120252802 A1 |
|
~%
461-78-9 |
| Literature: Pathway Therapeutics Inc. Patent: US2012/252802 A1, 2012 ; US 20120252802 A1 |
|
~%
461-78-9 |
| Literature: Ferrari,G. Farmaco, Edizione Scientifica, 1960 , vol. 15, p. 337 - 342 |
|
~%
461-78-9 |
| Literature: Ferrari,G. Farmaco, Edizione Scientifica, 1960 , vol. 15, p. 337 - 342 |
|
~%
461-78-9 |
| Literature: Pathway Therapeutics Inc. Patent: US2012/252802 A1, 2012 ; US 20120252802 A1 |
| Precursor 4 | |
|---|---|
| DownStream 3 | |
| HS Code | 2921499090 |
|---|---|
| Summary | 2921499090 other aromatic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |